Lotepred Eye Drop contains Loteprednol etabonate 0.5% w/v, a corticosteroid indicated for the treatment of inflammatory conditions of the eye, including allergic conjunctivitis, postoperative inflammation, and uveitis. Loteprednol etabonate exhibits potent anti-inflammatory properties by inhibiting the release of inflammatory mediators and suppressing leukocyte infiltration, thereby reducing ocular inflammation and associated symptoms such as redness, swelling, and discomfort. The formulation is designed for topical ophthalmic use, ensuring targeted delivery with minimal systemic absorption. Lotepred Eye Drop is typically administered as one or two drops into the affected eye(s) four times daily, with dosage adjustments based on clinical response. Caution is advised in patients with ocular infections, glaucoma, or a history of corticosteroid sensitivity. Prolonged use may increase the risk of elevated intraocular pressure and cataract formation; therefore, regular monitoring by an ophthalmologist is recommended. This medication should not be discontinued abruptly without medical consultation. Lotepred Eye Drop offers an effective therapeutic option for managing ocular inflammation while minimizing the adverse effects commonly associated with traditional corticosteroids. Patients should adhere strictly to prescribed dosing regimens and report any adverse reactions promptly.